Zhong Lun advised LaNova Medicines in Completing its CNY 300 Million Series C1 Financing and Entering into Strategic Collaboration with Sino Biopharm. LaNova Medicines Technology (Shanghai)...
You must be a Standard 1 Year member to access this content.
Zhong Lun assisted Lianlian DigiTech Co., Ltd. on the offering. Lianlian DigiTech Co., Ltd. completed its initial public offering of overseas shares (H shares) and successful...
You must be a Standard 1 Year member to access this content.
Davis Polk and Maples and Calder advised CARsgen Therapeutics Holdings Limited, while Herbert Smith Freehills and Zhong Lun advised Goldman Sachs and UBS on the deal....
You must be a Standard 1 Year member to access this content.
